Boiron
BOI.PABOI.PA · Stock Price
Historical price data
Overview
Boiron is a global leader in homeopathic pharmaceuticals, with a mission to contribute to a more humane and sustainable form of medicine. Its core strategy is built on vertical integration—controlling the supply chain from raw material sourcing to global distribution—and geographic diversification, with strongholds in Europe and North America. The company has achieved a dominant market position through brand recognition, a vast OTC portfolio, and deep relationships with pharmacies and healthcare professionals. Its future hinges on navigating significant regulatory challenges, particularly in key markets, while exploring digital health services to enhance patient engagement.
Technology Platform
Proprietary, industrialized processes for the serial dilution and succussion (dynamization) of natural substances (botanical, mineral, biological) according to homeopathic pharmacopoeias, supported by vertical integration from raw material cultivation to finished product manufacturing.
Pipeline
5| Drug | Indication | Stage | Watch |
|---|---|---|---|
| placebo + Arnica and Bryonia | Aortic Valve Replacement | Approved | |
| Homeodent® + 1.4% Sodium Bicarbonate solution | Oropharynx Cancer | Phase 3 | |
| Gelsemium Sempervirens + Gelsemium Sempervirens + Placebo | Anxiety | Phase 3 | |
| BRN01 + Placebo | Breast Cancer | Phase 3 | |
| Cocculine® + placebo | Breast Cancer | Phase 3 |
Opportunities
Risk Factors
Competitive Landscape
Boiron competes with other homeopathic specialists (e.g., DHU, Weleda) and consumer health giants in the OTC space. Its most significant competition is the broader scientific and regulatory establishment, which challenges the efficacy of the entire homeopathic category, making advocacy and public perception management a core competitive activity.
